幽门螺旋杆菌治疗方法的最新进展  

Latest Progress in the Treatment of Helicobacter Pylori

作　　者：姜寅瑞 陈潇雅 冯昱宁 刘启家 卢楚湘 Yin-Rui Jiang;Xiao-Ya Chen;Yu-Ning Feng;Qi-Jia Liu;Chu-Xiang Lu(Logistics University Of People’s Armed Ploce Force,Tianjin 300300,China)

机构地区：[1]武警后勤学院学兵二大队,天津300300

出　　处：《临床医学前沿》2020年第1期11-13,共3页

摘　　要：作为一种革兰阳性杆菌,幽门螺旋杆菌(H.pylori)属于微需氧菌,在人体胃黏膜中广泛定植,且与黏膜相关淋巴瘤、上皮内瘤变、肠化生、胃黏膜萎缩、消化性溃疡、慢性胃炎等疾病关系密切。在治疗H.pylori感染的过程中,以往较为经典的方法涉及“三联方案”、“伴同疗法”、“序贯疗法”等。但近几年由于抗菌药物的广泛应用以及滥用现象的增多,其耐药性有所增高,且治疗效果不断降低,所以对H.pylori感染的治疗方法最新进展进行深入探究尤为关键。本文现结合部分国外研究成果和2016年全国H.pylori感染的处理共识,详细阐述了H.pylori治疗方法最新进展。As a Gram-positive bacterium,H.pylori is a microaerobic bacteria,which is widely colonized in human gastric mucosa and closely related to mucosa-associated lymphoma,intraepithelial neoplasia,intestinal metaplasia,and atrophy of gastric mucosa,peptic ulcer,chronic gastritis and other diseases.In the treatment of H.pylori infection,the previous classical methods involved“triple regimen”,“concomitant therapy”,“sequential therapy”and so on.However,in recent years,due to the widespread application of antibacterial drugs and the increase of abuse,the drug resistance has increased,and the therapeutic effect has been decreasing.Therefore,it is particularly critical to further explore the latest progress in the treatment of H.pylori infection.This article is a detailed review of the latest advances in H.pylori treatment methods,combining some foreign research results and the national consensus on the treatment of H.pylori infection in 2016.

关 键 词：幽门螺旋杆菌 治疗方法 最新进展 

分 类 号：R57[医药卫生—消化系统]